6 completed, 2 unknown, 1 not yet recruiting, 1 withdrawn. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
Follow Coronary Atherosclerosis: new trials by email Literature Review of Coronary Atherosclerosis trials Research Report on Coronary Atherosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events Bempedoic acid, Ezetimibe, Rosuvastatin - Coronary Atherosclerosis, Mixed Dyslipidemia | Phase 3 | Not yet recruiting | Daiichi Sankyo | 103 | 2026-09-30 | 2026-09-29 |
| Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis? Omega 3 - Coronary Atherosclerosis | Phase 3 | Unknown | University Hospital, Clermont-Ferrand | 30 | 2011-03-01 | 2012-10-03 |
| AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis Placebo, TriLipix - Coronary Atherosclerosis | Phase 3 | Withdrawn | Piedmont Healthcare | 2009-11-01 | 2024-12-18 | |
| Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH) Aged garlic extract and Coenzyme Q10 - Coronary Atherosclerosis, Coronary Artery Calcification | Phase 3 | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 65 | 2009-05-01 | 2015-03-12 |
| Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients Placebo, Aliskiren - Coronary Artery Disease (CAD), Coronary Atherosclerosis | Phase 3 | Completed | Novartis Pharmaceuticals | 613 | 2009-03-01 | 2014-06-03 |
| PIoglitazone for PrEvention of Restenosis in Diabetic Patients Pioglitazone, Placebo - Coronary Atherosclerosis, Coronary Restenosis | Phase 3 | Unknown | University of Rome Tor Vergata | 160 | 2008-07-01 | 2008-08-01 |
| CRESTOR Athero Imaging Head to Head IVUS Study Rosuvastatin, Atorvastatin - Coronary Atherosclerosis | Phase 3 | Completed | AstraZeneca | 2333 | 2008-01-01 | 2012-07-16 |
| Everolimus Stent in Patients With Coronary Artery Disease (CAD) coronary stent, stent - Coronary Artery Disease, Coronary Atherosclerosis | Phase 3 | Completed | San Giuseppe Moscati Hospital | 600 | 2007-03-01 | 2010-08-17 |
| STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study) Rimonabant (SR141716), Placebo - Coronary Atherosclerosis | Phase 3 | Completed | Sanofi | 839 | 2005-01-01 | 2009-04-20 |
| Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic Counseling, Interactive Education, Group Support - Diabetes, Dyslipidemia | Phase 3 | Completed | Providence VA Medical Center | 200 | 2003-07-01 | 2014-04-16 |
Coronary Artery Disease (10) · Diabetes Mellitus (2) · Coronary Restenosis (1) · Coronary Stenosis (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Hypercholesterolemia (1) · Hypertension (1)
Arterial Occlusive Diseases (10) · Arteriosclerosis (10) · Cardiovascular Diseases (10) · Coronary Disease (10) · Heart Diseases (10) · Myocardial Ischemia (10) · Vascular Diseases (10) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Lipid Metabolism Disorders (2) · Coronary Stenosis (1) · Dyslipidemias (1) · Hyperlipidemias (1)
Atorvastatin (2) · Rosuvastatin Calcium (2) · 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1) · Counseling (1) · Docosahexaenoic Acids (1) · Ezetimibe (1) · Fenofibrate (1) · Pioglitazone (1) · Rimonabant (1) · Self-Help Groups (1) · Stents (1) · aliskiren (1) · coenzyme Q10 (1)
AstraZeneca (1) · Daiichi Sankyo (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Novartis Pharmaceuticals (1) · Piedmont Healthcare (1) · Providence VA Medical Center (1) · San Giuseppe Moscati Hospital (1) · Sanofi (1) · University Hospital, Clermont-Ferrand (1) · University of Rome Tor Vergata (1)
Italy (6) · United States (6) · France (4) · Spain (4) · Australia (3) · Belgium (3) · Canada (3) · Poland (3) · Argentina (2) · Germany (2) · Hungary (2) · Netherlands (2) · Brazil (1) · Mexico (1) · Russia (1)
Francesco Romeo, MD (1) · Joseph Miller, MD (1) · Matthew J Budoff, MD (1) · Stephen J Nicholls, MBBS, PhD (1) · Wen-Chih Wu, MD (1)
PMID 18387931, PMID 19262209, PMID 22085316, PMID 23999933, PMID 24043299, PMID 24448227, PMID 25240453, PMID 26523993
2008 (1), 2025 (1)